Delivra Health Brands Reports Continued Growth with Positive Adjusted EBITDA(1) and Improved Financial Results for FY2024
Delivra Health Brands to Hold Conference Call to Discuss Results for the Year Ending June 30, 2024
Delivra Health Brands Announces Grant of Incentive Stock Options
Delivra Health and its Brands Dream Water TM and LivRelief TM Report Positive Adjusted EBITDA(1) for Third Quarter of Fiscal 2024
Delivra Health’s Dream Water® Brand to Launch its Immunity Support Sleep Shot in the Canadian Market
Delivra Health Brands Announces Adoption of a New Fixed Share Option Plan
Delivra Health and its Brands LivRelief TM and Dream Water TM Report Results for Second Quarter of Fiscal 2024
Delivra Health Brands' Dream Water® Brand Launches its Sleep Gummies into the Canadian Market